The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
ASSOCIATION OF GLUCAGON-LIKE PEPTIDE-1 AGONISTS WITH CIRRHOSIS AND HEPATOCELLULAR CANCER IN METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
SOCIETY: DDW All symposia are 90-minute sessions, led by two moderators, with a varying number of invited talks. The session may include Q&A which can be included within each speaker’s total presentation time (2-3 minutes at the end) or as a separate block within the session…